
An RNA editing technique called ‘exon skipping’ has shown preliminary success in treating a rare and severe form of muscular dystrophy that currently has no treatment.

In a phase three clinical trial, a new enzyme replacement therapy resulted in a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency.

In a recent study, Shuang Zhang, a fourth year student in the Driskill Graduate Program in the Life Sciences (DGP), shed light on a molecule that mediates cross-talk between cardiac cells and immune cells after injury.

A recent study shows that patients treated for colon cancer who regularly drank caffeinated coffee had lower rates of cancer recurrence and mortality.

Medical students gathered to share their Area of Scholarly Concentration research projects with faculty and peers at a recent poster session.

New faculty members, Guillermo Oliver, PhD, and Beatriz Sosa-Pineda, PhD, joined the Department of Medicine and the Feinberg Cardiovascular Research Institute.

The NUCATS Institute and the Innovation and New Ventures Office recently announced the recipients of funding to assist promising biomedical research and moving it into a self-supporting commercial pathway.

A new study demonstrates how herpes viruses switch between two invasive states to promote infection in the nervous system.

A $7.4 million grant from the National Institutes of Health supports a second phase of basic science research to identify novel targets for treating uterine fibroids.

A team of researchers from Lurie Children’s, Rush University, the University of Illinois at Chicago, the University of Chicago and the Howard Brown Health Center has received funding from the National Institutes of Health to integrate substance use screening and brief intervention into the traditional community-based HIV testing environment.